Literature DB >> 22835007

The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costs.

Paul C Langley1.   

Abstract

OBJECTIVES: The purpose of this paper is to estimate the impact of the severity and frequency of pain on health-related quality-of-life (HRQoL), self-reported health status, and direct medical costs in Germany.
METHODS: Data are from the internet-based 2010 National Health and Wellness Survey (NHWS). Estimates of the impact of pain experience are generated by a series of regression models. In the case of HRQoL the physical and mental summary scores from the SF-12, together with SF-6D utilities, are evaluated within an ordinary least squares framework. Health status is assessed through an ordered logit model. Direct medical costs are estimated through a semi-logarithmic healthcare cost function. Socioeconomic characteristics, health risk behaviors, and the Charlson Comorbidity Index (CCI) are introduced as control variables in all regressions.
RESULTS: An estimated 23.96% of the adult German population (16.39 million) reported experiencing pain in the last 30 days. Of these 13.16% reported severe pain. The experience of frequent severe and moderate pain has a significant deficit impact on HRQoL. For those experiencing severe daily pain, the deficit in the SF-12 physical component score (PCS) is -17.930 (95% CI: -18.720 to -17.140), the SF-12 mental component score (MCS) is -8.787 (05% CI: -9.857 to -7.716), and SF-6D absolute utilities -0.201 (95% CI: -0.214 to -0.188); with self-reported health status the deficit impact of severe daily pain is also substantial (OR=29.000; 95% CI: 23.000-36.580). In the case of direct medical costs severe daily pain increases healthcare provider costs by 101.6% and total direct costs by 123.9%. LIMITATIONS: The NHWS is an internet survey. The principal limitation is that as a self-report there is no separate validation of pain severity or chronicity.
CONCLUSIONS: The experience of pain has a substantial negative impact on HRQoL, health status, and resource utilization in Germany. If pain is considered as a disease in its own right, the experience of chronic pain presents policy-makers with a major challenge.

Entities:  

Mesh:

Year:  2012        PMID: 22835007     DOI: 10.3111/13696998.2012.716383

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  13 in total

1.  The relationship between SF-6D utility scores and lifestyle factors across three life stages: evidence from the Australian Longitudinal Study on Women's Health.

Authors:  Jeeva Kanesarajah; Michael Waller; Jennifer A Whitty; Gita D Mishra
Journal:  Qual Life Res       Date:  2017-02-03       Impact factor: 4.147

2.  Chronic pain patients' treatment preferences: a discrete-choice experiment.

Authors:  Axel C Mühlbacher; Uwe Junker; Christin Juhnke; Edgar Stemmler; Thomas Kohlmann; Friedhelm Leverkus; Matthias Nübling
Journal:  Eur J Health Econ       Date:  2014-06-21

3.  Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

Authors:  Lisa A Uebelacker; Risa B Weisberg; Debra S Herman; Genie L Bailey; Megan M Pinkston-Camp; Michael D Stein
Journal:  Pain Med       Date:  2015-06-27       Impact factor: 3.750

4.  Chronic pain and depression among primary care patients treated with buprenorphine.

Authors:  Michael D Stein; Debra S Herman; Genie L Bailey; John Straus; Bradley J Anderson; Lisa A Uebelacker; Risa B Weisberg
Journal:  J Gen Intern Med       Date:  2015-02-13       Impact factor: 5.128

5.  [Prevalence of chronic pain in Germany. A representative survey of the general population].

Authors:  W Häuser; G Schmutzer; A Hinz; A Hilbert; E Brähler
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

6.  The effects of integrative in-patient treatment on patients' quality of life: a meta-analysis.

Authors:  Thomas Ostermann; Jost Langhorst; Andre-Michael Beer
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-28       Impact factor: 2.629

7.  Estimating the health care burden of prescription opioid abuse in five European countries.

Authors:  Amie Shei; Matthew Hirst; Noam Y Kirson; Caroline J Enloe; Howard G Birnbaum; William C N Dunlop
Journal:  Clinicoecon Outcomes Res       Date:  2015-09-15

Review 8.  Quality assessment of randomized control trials applied psychotherapy for chronic pains in iran: a systematic review of domestic trials.

Authors:  Fakhrudin Faizi; Abbas Tavallaee; Aboulfazl Rahimi; Amin Saburi; Masoud Saghafinia
Journal:  Iran Red Crescent Med J       Date:  2014-09-05       Impact factor: 0.611

9.  Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice.

Authors:  Michael A Ueberall; Alice Eberhardt; Gerhard Hh Mueller-Schwefe
Journal:  Int J Gen Med       Date:  2016-02-24

10.  The effect of a lay-led, group-based self-management program for patients with chronic pain: a randomized controlled trial of the Danish version of the Chronic Pain Self-Management Programme.

Authors:  Mimi Mehlsen; Lea Hegaard; Eva Ørnbøl; Jens Søndergaard Jensen; Per Fink; Lisbeth Frostholm
Journal:  Pain       Date:  2017-08       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.